FiercePharmaOriginal article
{"a":[{"_":"FDA rebukes 2 Indian API plants over data controls, sanitation issues","$":{"href":"/manufacturing/fda-rebukes-two-indian-api-drugmakers-data-controls-sanitation-mislabeling","hreflang":"en"}}]}
RegulatoryNegative
AI Analysis
Summary
The FDA issued warning letters to two Indian API manufacturers for deficiencies including poor record keeping, sanitation issues, and licensing problems. The action reflects regulatory enforcement against manufacturing non-compliance at active pharmaceutical ingredient suppliers.
Outcome Details
Warning letters issued for poor record keeping, sanitation problems, and licensing issues
Importance:5/10
Sentiment:
-0.80
FDA warning lettermanufacturing complianceAPI manufacturersIndiadata controlssanitationregulatory
Read the original article
Published by FiercePharma on July 23, 2026 7:57 AM